|
1
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma W, Wong CC, Tung EK, Wong CM and Ng IO:
RhoE is frequently downregulated in HCC and suppresses HCC invasion
through antagonizing the Rho/ROCK/MYPT pathway. Hepatology.
57:152–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berge G and Maelandsmo GM: Evaluation of
potential interactions between the metastasis-associated protein
S100A4 and the tumor suppressor protein p53. Amino Acids.
41:863–873. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mishra SK, Siddique HR and Saleem M:
S100A4 calcium-binding protein is key player in tumor progression
and metastasis: preclinical and clinical evidence. Cancer
Metastasis Rev. 31:163–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambartsumian N, Klingelhofer J, Grigorian
M, et al: The metastasis-associated Mts1(S100A4) protein could act
as an angiogenic factor. Oncogene. 20:4685–4695. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saleem M, Kweon MH, Johnson JJ, et al:
S100A4 accelerates tumorigenesis and invasion of human prostate
cancer through the transcriptional regulation of matrix
metalloproteinase 9. Proc Natl Acad Sci USA. 103:14825–14830. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stein U, Arlt F, Walther W, et al: The
metastasis-associated gene S100A4 is a novel target of
beta-catenin/T-cell factor signaling in colon cancer.
Gastroenterology. 131:1486–1500. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takenaga K, Nakanishi H, Wada K, et al:
Increased expression of S100A4, a metastasis-associated gene, in
human colorectal adenocarcinomas. Clin Cancer Res. 3:2309–2316.
1997.PubMed/NCBI
|
|
9
|
Ilg EC, Schafer BW and Heizmann CW:
Expression pattern of S100 calcium-binding proteins in human
tumors. Int J Cancer. 68:325–332. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hao H, Liu J, Liu G, et al: Depletion of
GRIM-19 accelerates hepatocellular carcinoma invasion via inducing
EMT and loss of contact inhibition. J Cell Physiol. 227:1212–1219.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu K, Dai Z, Pan Q, et al: Metadherin
promotes hepatocellular carcinoma metastasis through induction of
epithelial-mesenchymal transition. Clin Cancer Res. 17:7294–7302.
2011. View Article : Google Scholar
|
|
13
|
Wang J, Chen L, Li Y and Guan XY:
Overexpression of cathepsin Z contributes to tumor metastasis by
inducing epithelial-mesenchymal transition in hepatocellular
carcinoma. PLoS One. 6:e249672011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nagai T, Arao T, Furuta K, et al:
Sorafenib inhibits the hepatocyte growth factor-mediated epithelial
mesenchymal transition in hepatocellular carcinoma. Mol Cancer
Ther. 10:169–177. 2011. View Article : Google Scholar
|
|
15
|
Xia L, Huang W, Tian D, et al:
Overexpression of forkhead box C1 promotes tumor metastasis and
indicates poor prognosis in hepatocellular carcinoma. Hepatology.
57:610–624. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Strutz F, Okada H, Lo CW, et al:
Identification and characterization of a fibroblast marker: FSP1. J
Cell Biol. 130:393–405. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui JF, Liu YK, Zhang LJ, et al:
Identification of metastasis candidate proteins among HCC cell
lines by comparative proteome and biological function analysis of
S100A4 in metastasis in vitro. Proteomics. 6:5953–5961. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tulchinsky EM, Georgiev GP and Lukanidin
EM: Novel AP-1 binding site created by DNA-methylation. Oncogene.
12:1737–1745. 1996.PubMed/NCBI
|
|
19
|
Cohn MA, Hjelmso I, Wu LC, Guldberg P,
Lukanidin EM and Tulchinsky EM: Characterization of Sp1, AP-1, CBF
and KRC binding sites and minisatellite DNA as functional elements
of the metastasis-associated mts1/S100A4 gene intronic enhancer.
Nucleic Acids Res. 29:3335–3346. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Liu ZL, Zhang KL, et al:
Methylation-associated silencing of S100A4 expression in human
epidermal cancers. Exp Dermatol. 18:842–848. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie R, Loose DS, Shipley GL, Xie S,
Bassett RL Jr and Broaddus RR: Hypomethylation-induced expression
of S100A4 in endometrial carcinoma. Mod Pathol. 20:1045–1054. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rehman I, Goodarzi A, Cross SS, et al: DNA
methylation and immunohistochemical analysis of the S100A4 calcium
binding protein in human prostate cancer. Prostate. 67:341–347.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rudland PS, Platt-Higgins A, Renshaw C, et
al: Prognostic significance of the metastasis-inducing protein
S100A4 (p9Ka) in human breast cancer. Cancer Res. 60:1595–1603.
2000.PubMed/NCBI
|
|
24
|
Lee WY, Su WC, Lin PW, Guo HR, Chang TW
and Chen HH: Expression of S100A4 and Met: potential predictors for
metastasis and survival in early-stage breast cancer. Oncology.
66:429–438. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang HY, Zhang JY, Cui JT, et al:
Expression status of S100A14 and S100A4 correlates with metastatic
potential and clinical outcome in colorectal cancer after surgery.
Oncol Rep. 23:45–52. 2010.PubMed/NCBI
|
|
26
|
Wang YY, Ye ZY, Zhao ZS, Tao HQ and Chu
YQ: High-level expression of S100A4 correlates with lymph node
metastasis and poor prognosis in patients with gastric cancer. Ann
Surg Oncol. 17:89–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yonemura Y, Endou Y, Kimura K, et al:
Inverse expression of S100A4 and E-cadherin is associated with
metastatic potential in gastric cancer. Clin Cancer Res.
6:4234–4242. 2000.PubMed/NCBI
|
|
28
|
Ikenaga N, Ohuchida K, Mizumoto K, et al:
S100A4 mRNA is a diagnostic and prognostic marker in pancreatic
carcinoma. J Gastrointest Surg. 13:1852–1858. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bandiera A, Melloni G, Freschi M, et al:
Prognostic factors and analysis of S100a4 protein in resected
pulmonary metastases from renal cell carcinoma. World J Surg.
33:1414–1420. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tarabykina S, Griffiths TR, Tulchinsky E,
Mellon JK, Bronstein IB and Kriajevska M: Metastasis-associated
protein S100A4: spotlight on its role in cell migration. Curr
Cancer Drug Targets. 7:217–228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Santamaria-Kisiel L, Rintala-Dempsey AC
and Shaw GS: Calcium-dependent and -independent interactions of the
S100 protein family. Biochem J. 396:201–214. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ambartsumian NS, Grigorian MS, Larsen IF,
et al: Metastasis of mammary carcinomas in GRS/A hybrid mice
transgenic for the mts1 gene. Oncogene. 13:1621–1630.
1996.PubMed/NCBI
|
|
33
|
Maelandsmo GM, Hovig E, Skrede M, et al:
Reversal of the in vivo metastatic phenotype of human tumor cells
by an anti-CAPL (mts1) ribozyme. Cancer Res. 56:5490–5498.
1996.PubMed/NCBI
|
|
34
|
Takenaga K, Nakamura Y and Sakiyama S:
Expression of antisense RNA to S100A4 gene encoding an S100-related
calcium-binding protein suppresses metastatic potential of
high-metastatic Lewis lung carcinoma cells. Oncogene. 14:331–337.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moriyama-Kita M, Endo Y, Yonemura Y, et
al: S100A4 regulates E-cadherin expression in oral squamous cell
carcinoma. Cancer Lett. 230:211–218. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schmidt-Hansen B, Ornas D, Grigorian M, et
al: Extracellular S100A4(mts1) stimulates invasive growth of mouse
endothelial cells and modulates MMP-13 matrix metalloproteinase
activity. Oncogene. 23:5487–5495. 2004. View Article : Google Scholar : PubMed/NCBI
|
